H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.